Predicting How a Patient Will Respond to Mesothelioma Treatment
| |

Predicting How a Patient Will Respond to Mesothelioma Treatment

Malignant pleural mesothelioma is a rare cancer. Early diagnosis is challenging. Treatments are the first clinical option in the advanced disease stage. A doctor’s initial clinical response says a lot about the patient’s prognosis. It may even represent a useful way to identify patients with a better long-term outcome. A new Italian study from the Journal of Clinical Medicine looks at this possibility. First Mesothelioma Treatment Response Options Scientists looked at the initial treatment response in 46 mesothelioma patients who had pleural mesothelioma. None of these patients had surgery as an option because their tumors were considered inoperable. The doctor’s initial treatment response included a CT scan and clinical examination. This examination was usually after 2–3 cycles of drug therapy….

Decisions About Pleural Effusion in Mesothelioma: New Tool May Help
| | | | |

Decisions About Pleural Effusion in Mesothelioma: New Tool May Help

Researchers in the UK have developed a new tool that may help patients with mesothelioma and other pleural cancers make decisions about pleural effusion.  Pleural effusion is the buildup of excess fluid in the space around the lungs. It is a common side effect in people with advanced lung or breast cancer or pleural mesothelioma.  It can be complicated and time-consuming to make decisions about pleural effusion treatment. There are many different ways to handle the problem.  The UK research team developed a web-based decision support tool with input from patients, clinicians, and caregivers. The tool uses videos and questions to help patients decide on the best course of treatment for their unique situation. Pleural Effusion and Treatment Options The pleura…